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Abstract
Background—Clostridium difficile infection (CDI) is associated with medical care and may
cause readmission following hospitalization for any reason. The incidence of readmissions due to
CDI is not well known.
Design—Retrospective cohort study of adult inpatients in one county from 2000–2007, using
mandatory hospital discharge data.
Setting—All hospitals in Orange County, California
Patients—All adult inpatients readmitted with new-onset Clostridium difficile infection within
12 weeks of discharge.
Measurements—We assessed trends in hospital-associated CDI (HA-CDI) incidence, with and
without inclusion of post-discharge CDI (PD-CDI) events resulting in re-hospitalization within 12
weeks of discharge. We measured the effect of including PD-CDI events on hospital-specific CDI
incidence, a mandatory reporting measure in California, and on relative hospital ranks by CDI
incidence.
Results—From 2000 to 2007, countywide hospital-onset CDI (HO-CDI) incidence increased
from 15/10,000 to 22/10,000 admissions. When including PD-CDI events, HA-CDI incidence
doubled (29/10,000 in 2000 and 52/10,000 in 2007). Overall, including PD-CDI events resulted in
significantly higher hospital-specific CDI incidence, although hospitals had disproportionate
amounts of HA-CDI occurring post-discharge. This resulted in substantial shifts in some hospitals’
rankings by CDI incidence. In multivariate models, both HO and PD-CDI were associated with
increasing age, higher length of stay, and select comorbidities. Race and Hispanic ethnicity were
predictive of PD-CDI but not HO-CDI.
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Limitations—PD-CDI incidence may be underestimated since outpatient events were not
evaluated. Inaccuracies in claims data may cause under or over-estimation of CDI cases. Whether
C. difficile was acquired in the hospital or community post-discharge for PD-CDI is not known.
Conclusions—PD-CDI events associated with re-hospitalization are increasingly common. The
majority of HA-CDI cases now may be occurring post-discharge, raising important questions
about both accurate reporting and effective prevention strategies. Some risk factors for PD-CDI
may be different than those for HO-CDI, allowing additional identification of high-risk groups
before discharge.
INTRODUCTION
Hospital length of stay has steadily decreased over the past 30 years1 and increasingly
complex medical care is provided after discharge through home health and skilled nursing
facilities. In turn, adverse events related to hospitalization, including hospital-associated
infection, may increasingly present after discharge and result in readmission.2–5 The costs
and sequelae of hospital readmission have made it a target for hospital quality indicators and
value based purchasing. 6,7 Currently, the Centers for Medicare and Medicaid Services
reports hospitals’ rates of readmission following treatment for myocardial infarction,
congestive heart failure and pneumonia, prompting a national focus on preventing
readmission.8 However, readmission rates for other important conditions, such as hospital-
associated infections (HAIs), are not well studied despite national and state requirements for
reporting hospital-specific rates of HAIs.9–12
Clostridium difficile infection (CDI) is a common cause of diarrhea in healthcare settings
and may be an important source of hospital readmissions.13–15 Hospital-associated C.
difficile acquisition may not be evident until after hospital discharge, especially since the
average hospital length of stay is 3–5 days and acquisition may initially be
asymptomatic.1,16 In addition, risk factors related to medical care, such as predisposing
antibiotics, may require time to deplete the normal intestinal flora and allow C. difficile to
flourish and produce symptoms. The exact incubation period for CDI is unknown, but three
studies found the incubation period to be less than 1 week.22,23 However, several studies
have found patients may be at an increased risk for developing CDI up to 3 months after
hospital discharge.18–21 One recent study found that among patients who developed CDI
within 100 days post-discharge, 89% of patients developed CDI in the first 60 days and 85%
occurred in the first month.17 To account for the range of incubation period, national
guidance considers CDI occurring within 4 weeks of hospitalization as hospital-associated,
and CDI occurring within 4–12 weeks of a hospitalization as potentially hospital-
associated.22,23
Concerns about CDI have been increasing in the US. Hospitals’ incidence of CDI has been
rising in the past decade. This has been associated with the emergence of a new epidemic
strain, BI/NAP1/027, that produces 20-fold more toxin than other strains and is associated
with high rates of colectomy and death.24–28 In fact, there is evidence in some hospitals that
CDI prevalence may have surpassed that of methicillin-resistant Staphylococcus aureus
(MRSA).29 With continued pressure to reduce hospital length-of-stay, the frequency of post-
discharge CDI (PD-CDI) and the opportunity for prevention may be increasing as well.
In response to rising CDI incidence, the Centers for Disease Control and Prevention (CDC)
and the Society for Healthcare Epidemiology of America (SHEA) have recommended
surveillance of HA-CDI rates.9,10 In addition, reporting of CDI rates has been legislated or
is under legislative consideration in several states.30,31 Despite national guidance that post-
discharge CDI events occurring within 4 weeks should be considered hospital associated and
events between 4–12 weeks of discharge could potentially be hospital-associated, hospitals
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performing CDI surveillance often do not track PD-CDI events. However, tracking post-
discharge events may facilitate efforts to prevent readmissions and may be helpful for
reporting hospital-specific CDI incidence. Moreover, patients requiring readmission for PD-
CDI may not return to the original facility, suggesting that the incidence of HA-CDI may be
significantly underestimated if PD-CDI events are not uniformly identified among
hospitals.14
We sought to identify CDI cases occurring at all hospitals in a large California county
(population 3 million). We assessed the frequency of admission for new-onset CDI after a
recent hospitalization, and the impact of including PD-CDI events resulting in readmission
on hospital-specific CDI incidence.
METHODS
Description of Dataset
We conducted a population-based retrospective cohort study to assess the frequency of post-
discharge CDI events among adult inpatients in all 29 hospitals serving adults in Orange
County, California, from January 1, 2000 to December 31, 2007. We used mandatory
California hospital discharge data which provides line item demographic and insurer
information, ICD-9 codes (up to 25), and a unique identifier (Record Linking Number) that
allows patients to be tracked across hospital admissions.32 This data also includes a code to
indicate whether a given condition was present when the patient was admitted, known as the
Present on Admission (POA) code, which has been used in California since 1996.33
We identified CDI cases using the ICD-9 diagnostic code 008.45 for pseudomembranous
colitis. We defined four types of CDI cases: 1) hospital-onset CDI (HO-CDI) cases defined
by POA=N; 2) PD-CDI cases defined by POA=Y with a history of hospitalization for any
reason in the prior 12 weeks; 3) HA-CDI cases defined as the sum of HO-CDI and PD-CDI;
and 4) community-associated CDI (CA-CDI) cases defined by POA=Y with no prior history
of hospitalization in the previous 12 weeks. To reduce the chance that a code represented a
past history of CDI without active infection during hospitalization, we limited cases with
POA=Y to the first three coding positions. For POA=N cases, all coding positions were
accepted. We excluded 932 cases of recurrent CDI, defined as cases occurring within 8
weeks of a previous CDI episode.9,22 Finally, we assessed the fraction of post-discharge
events that occurred within 4 weeks of discharge. This study was approved by the
Institutional Review Boards of the University of California Regents and the California
Committee for the Protection of Human Subjects.
Data Analysis
Patient Characteristics—We collected demographic information for all patients in our
cohort, including gender, age, race and ethnicity, and insurance type. We also assessed the
proportion of hospitalized patients with select comorbidities using the Romano score33 and
the proportion that had undergone surgery in the previous month. These characteristics were
collected for all admissions and for those with CDI (HO-CDI, PD-CDI, and CA-CDI).
Annual Incidence of CDI—Annual CDI incidence across Orange County was determined
for 2000–2007 and analyzed by chi-square tests for trend. We identified all cases and
subsets of CDI as defined above. Incidences of HO-CDI, PD-CDI and HA-CDI were
expressed per 10,000 admissions. CA-CDI incidence was expressed per 100,000 residents.
Hospital Readmission for CDI—We defined a PD-CDI readmission as a case with
symptoms present on admission (POA=Y) that occurred within 12 weeks after a prior
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hospitalization for any reason, as described above. We calculated the percentage of all-cause
readmissions that are due to PD-CDI. We excluded readmissions for recurrent CDI, which
we defined as community-onset (POA=Y) cases readmitted within 8 weeks of a previous
admission for CDI.22 We also determined how often patients readmitted for PD-CDI went to
a different facility for their readmission. Finally, we assessed the fraction of PD-CDI that
occurred within 4 weeks of discharge.
Impact of Including Post-Discharge CDI Readmissions in Hospital-Specific
CDI Incidence—For each hospital, we determined the annual incidence of HO-CDI and
HA-CDI for the years 2000–2007. Differences between annual HO-CDI and HA-CDI
incidence were compared using paired t-tests. We determined whether relative rankings by
quartile of hospitals by CDI incidence were affected by inclusion of PD-CDI.
Identifying Individual and Hospital Predictors of CDI—We identified the primary
admission diagnoses of admissions that were associated with HO-CDI and PD-CDI. For
primary admission diagnoses associated with greater than 25 HO-CDI or PD-CDI events, we
calculated the frequency of CDI compared to those without that primary admission
diagnosis.
We performed bivariate analyses using chi-square tests to identify individual and hospital
level variables associated with the individual outcomes of HO-CDI and PD-CDI. For the
PD-CDI outcome, we used characteristics from the PD-CDI (vs. the index) admission and
removed all hospitalizations that resulted in death, since these hospitalizations could not
result in readmission. Individual variables included demographics, comorbidities, primary
admission diagnosis, recent surgery, insurance type, year of hospital admission, and length-
of-stay. Hospital variables included annual admissions, average length-of-stay, and hospital
type (acute vs. long-term acute care facility). Variables with p<0.1 from bivariate testing
were entered into a generalized linear mixed model which accounted for clustering by
hospital (ProcGLIMMIX, SAS9.2, Cary, NC). Variables were retained at alpha=0.05.
RESULTS
Patient Characteristics
Patients admitted with CDI were older, had more comorbidities, and were less likely to have
undergone surgery in the past month compared to all hospitalized patients (Table 1). Among
those with CDI, patients with HO-CDI and PD-CDI had similar distributions of age, race
and ethnicity, and comorbidities, but those with HO-CDI were more likely to be male and to
have undergone surgery in the past month.
Annual Incidence of HO-CDI and HA-CDI
Annual incidence of HO-CDI in Orange County increased from 2000 to 2007, as shown in
Figure 1 (p<0.001 for test of trend). After including PD-CDI events, the annual incidence of
HA-CDI increased 1.9-fold during the same period, from 28 to 52 per 10,000 admissions
(chi-square, p<0.001). By 2007, PD-CDI composed the majority of HA-CDI cases
(increasing from 46% in 2000 to 57% in 2007, p<0.001 for test of trend).
Frequency of New-Onset CDI as Reason for Hospital Readmission
Over 2000–2007, PD-CDI events resulting in readmission represented 1.8% (2,998 of
170,995) of all-cause readmissions within 12 weeks after discharge. When evaluating all
admissions related to CDI occurring within 365 days of discharge, we found that the risk of
readmission for CDI was higher in the first 12 weeks post-discharge, and highest in the first
4 weeks post-discharge (Figure 2). Of PD-CDI event occurring within 12 weeks of
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discharge, 58% (624 of 1071) occurred within the 4 weeks after discharge. After 12 weeks,
the risk of readmission for CDI dropped to a stable, low level. Among PD-CDI cases
readmitted within 12 weeks, 25% (746 of 2,998) were readmitted to a different hospital than
the initial hospitalization.
Impact of Including CDI Readmissions on Hospital-Specific Rates
Figure 3 shows hospital-specific rankings according to CDI incidence for 2007, with and
without including PD-CDI events (HO-CDI vs. HA-CDI, respectively). The proportion of
hospitals’ HA-CDI comprised by PD-CDI varied greatly (median 60% PD-CDI, range 0–
100%, for 2007). Hospital ranking by CDI incidence changed by a mean of 3 places after
including PD-CDI events; only 5 of 29 hospitals did not change rank. Three hospitals
became ranked in the worst quartile after including PD-CDI, including one hospital that had
been ranked in the best quartile when PD-CDI events were excluded. Another 3 hospitals
were no longer ranked in the worst quartile when PD-CDI events were included.
Identifying Individual and Hospital Predictors of CDI
Primary admission diagnoses that occurred most often during HO-CDI and PD-CDI
admissions are listed in Table 3. Several primary admission diagnoses were significantly
associated with both HO-CDI and PD-CDI admissions on bivariate analysis, including
septicemia, pneumonia, post-operative infection and urinary tract infection.
Results from bivariate analysis (Table 2) were similar to those from multivariate analysis
(Table 4). In multivariate analysis, HO-CDI and PD-CDI were both associated with
increasing age, longer length of stay, Medicare insurance, recent surgery, comorbidities,
select primary admission diagnoses (septicemia, post-operative infection and pneumonia),
and hospitals with a high percent of patients with a high comorbidity index. Non-white race,
Hispanic ethnicity and male gender were protective against PD-CDI, but not HO-CDI.
Annual Incidence of Community-Associated CDI
Orange County’s incidence of CA-CDI also rose during 2000 to 2007. In this period, CA-
CDI incidence increased 2.1-fold from 9 to 19 cases per 100,000 residents (chi-square,
p<0.001), exclusive of PD-CDI cases.
DISCUSSION
C. difficile disease is a major cause of healthcare-associated infection and morbidity. Due to
the known delay in presentation following antibiotic exposure, national guidelines consider
cases up to 12 weeks following hospital discharge as potentially healthcare-associated and
possibly preventable. Nevertheless, the majority of hospitals do not track post-discharge
cases, and the impact of post-discharge cases has remained largely unknown. Remarkably,
we found that PD-CDI cases within 12 weeks after hospital discharge accounted for the
majority of HA-CDI and led to a 2-fold increase in HA-CDI incidence across hospitals in a
large metropolitan county. This finding illustrates the need to expand prevention and
education strategies to include the post-discharge period and thereby reduce the frequency of
PD-CDI events.
Inclusion of post-discharge CDI events substantially altered hospital-specific CDI incidence,
but the impact varied widely by hospital. For example, PD-CDI cases accounted for all HA-
CDI cases in one hospital and none of the cases in another. This suggests that tracking PD-
CDI events may impact the validity of inter-facility comparisons, since hospitals are affected
differentially by including or excluding PD-CDI. These discrepancies could be magnified if
some, but not all, hospitals track PD-CDI. When we ranked hospitals by HO-CDI incidence,
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half the hospitals captured in the quartile with the highest HO-CDI incidence changed when
PD-CDI was included. In fact, one hospital changed from the best quartile to the worst
quartile when PD-CDI cases were captured. In addition, since 75% of patients with PD-CDI
returned to the same hospital for readmission, hospitals may be able to track most PD-CDI
cases by performing post-discharge surveillance for PD-CDI cases that readmit to their own
facility. Additional notification of PD-CDI cases back to transferring or recently discharging
hospitals may also improve accuracy of CDI rates.
For prevention, patient characteristics may be utilized to identify populations at elevated risk
for post-discharge CDI. We found that risk factors for HO-CDI and PD-CDI were often the
same, including increasing age, higher length of stay, and overall poor health, including
diabetes, cancer, and AIDS. In addition, prevention may be targeted at patients with specific
primary admission diagnoses such as septicemia, post-operative infection, and pneumonia.
These primary admission diagnoses all represent conditions likely to be treated with
antibiotics, the main risk factor for CDI. The immediate post-discharge period should be
considered an extension of the risk of CDI that begins during a hospital stay. This heightens
the importance of educating high risk patients prior to hospital discharge about the potential
for post-discharge diarrhea and of identifying prophylactic solutions to prevent disease in
the high risk patient population.
In addition, we found that white and non-Hispanic patients had a higher risk of PD-CDI.
While we did not evaluate reasons for this difference, racial and ethnic disparities, including
access to healthcare, have been well-documented and may be magnified in the outpatient
arena.35–36 Differences in access to outpatient care are likely to impact antibiotic use in
these groups, and their subsequent risk of PD-CDI. In addition, male gender was associated
with lower risk of PD-CDI but not with HO-CDI. This difference may not be due to an
increased post-discharge risk for women but may instead reflect men’s reduced tendency to
seek care and therefore be hospitalized for PD-CDI.37–39 More research is needed to
understand the reasons for differential risk in these groups in order to develop effective
prevention strategies for the post-discharge setting.
Our study has several limitations. We did not capture PD-CDI cases treated in the outpatient
setting, which may have led to an underestimate of PD-CDI incidence. Nevertheless, the
focus on PD-CDI associated with re-hospitalization ensured capture of the most serious
cases. While errors present in administrative data may lead to an under or over estimation of
CDI incidence, this California dataset is notable for containing present on admission codes
that indicate hospital vs. community disease onset. These codes have been well established
in California hospitals for over a decade and have been validated for select diseases such as
community-acquired pneumonia and acute myocardial infarction.40 We also minimized the
chances that a code represented a history of CDI only versus active disease by limiting
diagnoses to the first 3 coded positions. Another limitation is that we did not account for
certain known risk factors (such as antibiotic use) that were unavailable in administrative
data. However, we included primary admission diagnoses that are frequently treated with
antibiotics. Finally, we attributed a PD-CDI event to the most recent hospitalization within
12 weeks. This definition does not account for multiple hospital exposures during that
period or for intervening nursing home admissions, which may also contribute to CDI
acquisition.41 Further, since the incubation period for CDI is unknown, some cases
occurring within our 12 week window may be due to exposures in the community, including
outpatient antibiotic use, household pets, and contamination of food.42–43 Nonetheless, over
half of PD-CDI cases detected in this study occurred within the first 4 weeks after discharge,
a time window that is accepted by national guidance to most likely reflect healthcare
associated CDI events.
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In summary, tracking PD-CDI cases doubled the incidence of HA-CDI in a large county.
Since the majority of hospitals do not track PD-CDI cases, the frequency and impact of PD-
CDI may be widely underestimated, resulting in missed opportunities to prevent
readmissions. Importantly for public reporting purposes, including PD-CDI affected
individual hospitals differently, leading to substantial changes in hospital rankings by CDI
incidence. Uniform tracking of PD-CDI events would allow more accurate estimates of
overall CDI incidence and more equitable hospital-to-hospital comparisons. We found that
the vast majority of cases can be captured if hospitals track PD-CDI cases that return to the
same facility. We also identified several patient characteristics that were associated with PD-
CDI, suggesting that preventative strategies may effectively focus upon specific patient
groups. Targeted education and prevention for CDI may become increasingly important to
help hospitals lower their readmission rates.
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CDI Burden among Hospitalized Adult Patients in Orange County, California, from 2000 to
2007. Incidence of HO-CDI, PD-CDI and HA-CDI is expressed per 10,000 adult
admissions; incidence of CA-CDI is expressed per 100,000 Orange County adult population.
HA-CDI consists of HO-CDI and PD-CDI.
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Time to Readmission for Post-Discharge CDI Cases (PD-CDI), 2000–2007, for Cases
Occurring within 1 Year after Discharge (N=1,766).
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Hospital-specific Rankings by HA-CDI vs. HO-CDI Incidence for 2007. Shaded areas
indicate the quartile of hospitals with the highest CDI incidence based upon HA-CDI vs
HO-CDI.
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Table 4
Multivariate Analysis of Predictors of Hospital-Onset CDI (HO-CDI) and Post-Discharge CDI (PD-CDI)
Among all Adult Inpatients
HO-CDI vs. All non HO-CDI PD-CDI vs. All non HO-CDI
Individual Variables OR (95% CI) p-value OR (95% CI) p-value
Age <0.001 <0.001
  18 – < 40 Reference Reference
  40 – 49 1.93 (1.29–2.89) 2.20 (1.53–3.17)
  50 – 59 1.82 (1.23–2.71) 2.21 (1.54–3.17)
  60 – < 75 1.83 (1.28–2.61) 2.76 (1.99–3.82)
  75+ 2.16 (1.51–3.09) 3.93 (2.85–5.44)
Male Gender 1.04 (0.93–1.16) 0.49 0.87 (0.80–0.95) 0.001
Race 0.01 <0.001
  White Reference Reference
  Black 0.94 (0.61–1.45) 0.49 (0.31–0.78)
  Asian 1.27 (1.06–1.52) 0.64 (0.53–0.77)
  Other 0.79 (0.59–1.05) 1.04 (0.85–1.28)
Hispanic Ethnicity 0.94 (0.77–1.15) 0.56 0.73 (0.62–0.86) <0.001
Medicare Insurance 0.61 (0.48–0.77) <0.001 0.70 (0.56–0.87) 0.001
Admission Year 1.07 (1.05–1.09) <0.001 1.11 (1.09–1.13) <0.001
  2000 (reference)
  2001 1.03 (0.81–1.33) 0.92 (0.75–0.86)
  2002 1.12 (0.88–1.43) 1.04 (0.86–1.27)
  2003 0.94 (0.73–1.21) 1.14 (0.94–1.38)
  2004 1.22 (0.96–1.55) 1.35 (1.12–1.62)
  2005 1.25 (0.99–1.58) 1.67 (1.40–1.99)
  2006 1.55 (1.24–1.94) 1.83 (1.53–2.18)
  2007 1.39 (1.10–1.74) 1.71 (1.43–2.04)
Length of Stay 1.02 (1.02–1.02) <0.001 1.01 (1.01–1.01) <0.001
Surgerya 2.16 (1.91–2.43) <0.001 1.23 (1.12–1.35) <0.001
Comorbidities
  Diabetes 1.36 (1.20–1.53) <0.001 1.14 (1.03–1.25) 0.009
  Cancer 1.32 (1.13–1.55) <0.001 1.24 (1.09–1.42) 0.001
  Dementia 1.57 (1.28–1.93) <0.001 1.03 (0.87–1.21) 0.74
  Ulcer 1.92 (1.49–2.47) <0.001 1.31 (1.04–1.67) 0.02
  AIDS 4.15 (2.02–8.50) <0.001 3.27 (1.60–6.65) 0.001
High Comorbidity Indexb 1.06 (1.02–1.11) <0.001 1.02 (1.01–1.03) 0.001
Primary Admission Diagnosis:
  Chemotherapy 7.08 (4.04–12.42) <0.001 ----------------------
  S.aureus Pneumonia 5.13 (3.23–8.16) <0.001 ----------------------
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HO-CDI vs. All non HO-CDI PD-CDI vs. All non HO-CDI
Individual Variables OR (95% CI) p-value OR (95% CI) p-value
  Infection due to Vascular Device 3.05 (1.87–4.97) <0.001 ----------------------
  Septicemia 2.70 (3.71–1.96) <0.001 3.55 (2.87–4.40) <0.001
  Post-operative Infection 2.36 (3.89–1.43) <0.001 2.39 (1.51–3.76) <0.001
  Acute Respiratory Failure 2.25 (1.63 – 3.10) <0.001 ----------------------
  Pneumonia 1.47 (1.93–1.11) 0.006 1.82 (1.54–2.16) <0.001
  Cellulitis ---------------------- 2.41 (1.72–3.38) <0.001
  Colon Diverticulitis ---------------------- 2.37 (1.64–3.43) <0.001
  Urinary Tract Infection ---------------------- 1.86 (1.48–2.33) <0.001
  Acute Renal Failure ---------------------- 1.73 (1.25–2.39) <0.001
a
Surgery indicates surgery during the current admission or within the previous 30 days
b
Comorbidity Index measured by Romano score
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